UlcerativeColitis:Pathogenesis * WalterFriesandSalvatoreComunale DivisionofChronicIntestinalDisorders,DepartmentofInternalMedicine,UniversityofMessina,Messina,Italy :Thepathogenesisofulcerativeisstillpoorlyunderstood.Withtheintroductionofnewculture-t techniquestheresearchontheintestinalmicrobiotahasrevealedanimportantreductionof...
Scientists are developing new treatments for ulcerative colitis (UC). There is ongoing scientific research into stem cell therapy for UC. Despite such developments, it remains an incurable condition. UC is an inflammatory condition that affects an individual’s colon. Its primary symptom is frequent...
Ulcerative colitis (UC) is a chronic relapsing–remitting inflammatory bowel disease (IBD) characterized by mucosal ulceration, rectal bleeding, diarrhea, and abdominal pain. In contrast to Crohn's disease (CD), UC is restricted to the colon and the inflammation is limited to the mucosal layer...
Symptoms and Conditions Associated With Ulcerative Colitis Most patients with ulcerative colitis have episodes of rectal bleeding, diarrhea and/or increased stool frequency occurring more than 3 times per day, bowel urgency, fecal incontinence, and crampy abdominal pain. Some individuals experience fatigue...
Ulcerative ColitisThrombocytopeniaChildrenWe report the case of a 14-year-old boy affected by ulcerative colitis (UC) and acute thrombocytopenic purpura (ITP) with simultaneous onset. UC diagnosis was based on symptoms, endoscopy and histology findings. ITP diagnosis was based on the normal bone ...
The present invention pertains to a method for treating ulcerative colitis in a human which comprises orally or rectally administering to the human a therapeutically effective amount of an antibody which binds to a colonic antigen associated with ulcerative colitis. In another embodiment, the present ...
B cells, which are critical for intestinal homeostasis, remain understudied in ulcerative colitis (UC). In this study, we recruited three cohorts of patients with UC (primary cohort, n = 145; validation cohort 1, n = 664; and validation cohort 2, n = 143) to comprehensively...
Magro, F.. Third european evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance., 649–670, . Development and validation of the nancy histological index for uc., 43–49, ...
The most significant advance in the past 50 years in the management of ulcerative colitis in relapse has been the development of corticosteroids. While they remain the mainstay in treatment for active disease, their short- and long-term toxicity has made their chronic administration at high doses...
The ulcerative colitis was classified as moderate and the patient was put on oral corticosteroids with degression. The evolution was marked by a clinical and biological improvement of pancreatitis and colitis. Conclusion: The association of idiopathic pancreatitis with ulcerative colitis is rare. The ...